Search
forLearn
1 / 1 resultsResearch
5 / 112 results
research Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
No definitive link between finasteride and male breast cancer, but further research is needed.
research Evaluation of Markers of Inflammation and Oxidative Stress in Patients with Premature Canities
Premature canities is linked to low vitamin D and B12, family history, and higher MHR.
research Assessment of Monocyte to High-Density Lipoprotein Ratio and Ischemia-Modified Albumin in Acne Vulgaris Patients
Higher ischemia-modified albumin levels are linked to acne severity.
research BH12 Efficacy and Safety of Hair Gloss Treatments: A Systematic Review of Licensed Products in the UK
Licensed hair gloss products improve shine and smoothness but require stricter regulation to ensure safety.
research Quantitative and Qualitative Analysis of Individual Experiences Post Botulinum Toxin Injection - United Kingdom Survey
Most UK survey participants had negative side effects from botulinum toxin injections, with many not fully recovering physically, emotionally, or financially.
Community Join
5 / 11 resultscommunity Finasteride is save in the eu (they concluded the investigation)
Finasteride and dutasteride are still available in the EU, with a warning about potential suicidal thoughts. The benefits of these treatments are deemed greater than the risks.
community Why aren’t hair fibers popular?
Hair fibers are discussed as a temporary solution for hair loss, with users noting they work well if applied correctly but can be messy and time-consuming. Some users also use finasteride for long-term treatment.
community 7 years minoxidil user. Is this the Time for HT ?
A 25-year-old has used minoxidil for 7 years, finasteride for 2 years, oral minoxidil and dutasteride for 3 months, and also tried microneedling and nizoral. They are considering a hair transplant but are concerned about being a good candidate due to potential retrograde alopecia.
community How likely do you think it is for PP405 to come out?
PP405 is a potential new hair loss treatment that works through metabolic pathways rather than hormonal ones, with an estimated market release between late 2027 and 2029. Current alternatives to finasteride include minoxidil, pyralutamide, fluridil, and RU58841, with hair transplants also being a viable option.
community Common hair-loss drug consistently associated with higher rates of psychiatric harm
Finasteride and dutasteride can cause psychiatric side effects like depression and suicidal thoughts in some users, especially those with a history of mental health issues. While some users experience positive hair growth results, others face severe psychological effects, raising concerns about their safety and the need for careful monitoring.